--Ocular Therapeutix, Inc., an integrated biopharmaceutical company committed to redefining the retina experience, today announced that the first patient has been randomized in the HELIOS-3 Phase 3 ...

— The French military Helios-2A reconnaissance satellite is known mainly for its high-resolution optical imagery, but its infrared sensor has produced better-than-expected data that is permitting the ...

PARIS — The French-led Helios 2B optical and infrared reconnaissance satellite launched Dec. 18, 2009, aboard an Ariane 5 GS rocket has successfully passed initial in-orbit checkout and delivered its ...

(MENAFN- GlobeNewsWire - Nasdaq) First patient randomized into HELIOS-3, which along with HELIOS-2 form the basis of AXPAXLI's registrational program in non-proliferative diabetic retinopathy (NPDR) ...